These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35976944)

  • 1. VItamin K In PEritonial DIAlysis (VIKIPEDIA): Rationale and study protocol for a randomized controlled trial.
    Roumeliotis S; Roumeliotis A; Georgianos PI; Thodis E; Schurgers LJ; Maresz K; Eleftheriadis T; Dounousi E; Tripepi G; Mallamaci F; Liakopoulos V
    PLoS One; 2022; 17(8):e0273102. PubMed ID: 35976944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Dephosphorylated-Uncarboxylated MGP in Hemodialysis patients: risk factors and response to vitamin K
    Aoun M; Makki M; Azar H; Matta H; Chelala DN
    BMC Nephrol; 2017 Jun; 18(1):191. PubMed ID: 28592319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin K2 supplementation and arterial stiffness among renal transplant recipients-a single-arm, single-center clinical trial.
    Mansour AG; Hariri E; Daaboul Y; Korjian S; El Alam A; Protogerou AD; Kilany H; Karam A; Stephan A; Bahous SA
    J Am Soc Hypertens; 2017 Sep; 11(9):589-597. PubMed ID: 28756183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial.
    Westenfeld R; Krueger T; Schlieper G; Cranenburg EC; Magdeleyns EJ; Heidenreich S; Holzmann S; Vermeer C; Jahnen-Dechent W; Ketteler M; Floege J; Schurgers LJ
    Am J Kidney Dis; 2012 Feb; 59(2):186-95. PubMed ID: 22169620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactive Matrix Gla Protein, Arterial Stiffness, and Endothelial Function in African American Hemodialysis Patients.
    Fain ME; Kapuku GK; Paulson WD; Williams CF; Raed A; Dong Y; Knapen MHJ; Vermeer C; Pollock NK
    Am J Hypertens; 2018 May; 31(6):735-741. PubMed ID: 29635270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of vitamin K2 supplementation on vascular calcification in haemodialysis patients: a 1-year follow-up randomized trial.
    Oikonomaki T; Papasotiriou M; Ntrinias T; Kalogeropoulou C; Zabakis P; Kalavrizioti D; Papadakis I; Goumenos DS; Papachristou E
    Int Urol Nephrol; 2019 Nov; 51(11):2037-2044. PubMed ID: 31529295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD.
    Schlieper G; Westenfeld R; Krüger T; Cranenburg EC; Magdeleyns EJ; Brandenburg VM; Djuric Z; Damjanovic T; Ketteler M; Vermeer C; Dimkovic N; Floege J; Schurgers LJ
    J Am Soc Nephrol; 2011 Feb; 22(2):387-95. PubMed ID: 21289218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dephosphorylated-uncarboxylated Matrix Gla protein concentration is predictive of vitamin K status and is correlated with vascular calcification in a cohort of hemodialysis patients.
    Delanaye P; Krzesinski JM; Warling X; Moonen M; Smelten N; Médart L; Pottel H; Cavalier E
    BMC Nephrol; 2014 Sep; 15():145. PubMed ID: 25190488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin K supplementation and arterial calcification in dialysis: results of the double-blind, randomized, placebo-controlled RenaKvit trial.
    Levy-Schousboe K; Frimodt-Møller M; Hansen D; Peters CD; Kjærgaard KD; Jensen JD; Strandhave C; Elming H; Larsen CT; Sandstrøm H; Brasen CL; Schmedes A; Madsen JS; Jørgensen NR; Frøkjær JB; Frandsen NE; Petersen I; Marckmann P
    Clin Kidney J; 2021 Sep; 14(9):2114-2123. PubMed ID: 34476095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment to reduce vascular calcification in hemodialysis patients using vitamin K (Trevasc-HDK): A study protocol for a randomized controlled trial.
    Haroon SW; Tai BC; Ling LH; Teo L; Davenport A; Schurgers L; Teo BW; Khatri P; Ong CC; Low S; Yeo XE; Tan JN; Subramanian S; Chua HR; Tan SY; Wong WK; Lau TW
    Medicine (Baltimore); 2020 Sep; 99(36):e21906. PubMed ID: 32899022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactive Matrix Gla-Protein Is Associated With Arterial Stiffness in an Adult Population-Based Study.
    Pivin E; Ponte B; Pruijm M; Ackermann D; Guessous I; Ehret G; Liu YP; Drummen NE; Knapen MH; Pechere-Bertschi A; Paccaud F; Mohaupt M; Vermeer C; Staessen JA; Vogt B; Martin PY; Burnier M; Bochud M
    Hypertension; 2015 Jul; 66(1):85-92. PubMed ID: 25987667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin K1 to slow vascular calcification in haemodialysis patients (VitaVasK trial): a rationale and study protocol.
    Krueger T; Schlieper G; Schurgers L; Cornelis T; Cozzolino M; Jacobi J; Jadoul M; Ketteler M; Rump LC; Stenvinkel P; Westenfeld R; Wiecek A; Reinartz S; Hilgers RD; Floege J
    Nephrol Dial Transplant; 2014 Sep; 29(9):1633-8. PubMed ID: 24285427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of vitamin K supplementation on serum calcification propensity and arterial stiffness in vitamin K-deficient kidney transplant recipients: A double-blind, randomized, placebo-controlled clinical trial.
    Eelderink C; Kremer D; Riphagen IJ; Knobbe TJ; Schurgers LJ; Pasch A; Mulder DJ; Corpeleijn E; Navis G; Bakker SJL; de Borst MH; Te Velde-Keyzer CA
    Am J Transplant; 2023 Apr; 23(4):520-530. PubMed ID: 36695702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic and Vascular Vitamin K Status in Patients with High Cardiovascular Risk.
    Rapp N; Brandenburg VM; Kaesler N; Bakker SJL; Stöhr R; Schuh A; Evenepoel P; Schurgers LJ
    Nutrients; 2021 Oct; 13(10):. PubMed ID: 34684491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactive Matrix Gla-Protein and Arterial Stiffness in Type 2 Diabetes Mellitus.
    Sardana M; Vasim I; Varakantam S; Kewan U; Tariq A; Koppula MR; Syed AA; Beraun M; Drummen NE; Vermeer C; Akers SR; Chirinos JA
    Am J Hypertens; 2017 Feb; 30(2):196-201. PubMed ID: 27927630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Dephospho-Uncarboxylated Matrix Gla-Protein Is Associated With Kidney Dysfunction and Arterial Stiffness.
    Puzantian H; Akers SR; Oldland G; Javaid K; Miller R; Ge Y; Ansari B; Lee J; Suri A; Hasmath Z; Townsend R; Chirinos JA
    Am J Hypertens; 2018 Aug; 31(9):988-994. PubMed ID: 29788226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin K Supplementation for Prevention of Vascular Calcification in Chronic Kidney Disease Patients: Are We There Yet?
    Roumeliotis S; Duni A; Vaios V; Kitsos A; Liakopoulos V; Dounousi E
    Nutrients; 2022 Feb; 14(5):. PubMed ID: 35267901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Menaquinone-7 Supplementation to Reduce Vascular Calcification in Patients with Coronary Artery Disease: Rationale and Study Protocol (VitaK-CAC Trial).
    Vossen LM; Schurgers LJ; van Varik BJ; Kietselaer BL; Vermeer C; Meeder JG; Rahel BM; van Cauteren YJ; Hoffland GA; Rennenberg RJ; Reesink KD; de Leeuw PW; Kroon AA
    Nutrients; 2015 Oct; 7(11):8905-15. PubMed ID: 26516910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin K2 supplementation in haemodialysis patients: a randomized dose-finding study.
    Caluwé R; Vandecasteele S; Van Vlem B; Vermeer C; De Vriese AS
    Nephrol Dial Transplant; 2014 Jul; 29(7):1385-90. PubMed ID: 24285428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin K for the Treatment of Cardiovascular Disease in End-Stage Renal Disease Patients: Is there Hope?
    Roumeliotis S; Roumeliotis A; Dounousi E; Eleftheriadis T; Liakopoulos V
    Curr Vasc Pharmacol; 2021; 19(1):77-90. PubMed ID: 32196451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.